HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT.

AbstractAIM:
The aim of this study is to ascertain the high somatostatin receptor (SSTR) uptake in spleen and to compare the uptake in spleen and splenosis using SSTR PET/CT using( 68)Ga-DOTATOC.
MATERIALS AND METHODS:
SUV(max) of spleen on (68)Ga-DOTATOC SSTR PET/CT (acquired for initial staging) in 10 patients with known neuroendocrine neoplasm of pancreatic tail was analyzed. All patients underwent left pancreatectomy and splenectomy. Diagnosis of splenosis was confirmed on CT, and SUV(max) was noted on follow-up SSTR PET/CT.
RESULTS:
SUV(max)was 28.8 ± 12.5 in normal spleen and 10.5 ± 4.3 in splenosis.
CONCLUSION:
The high uptake of( 68)Ga-DOTATOC (which has a high affinity to SSTR 2) in the spleen as compared to splenosis, which has a different histology, suggests white pulp as the probable site of high SSTR 2 expression.
AuthorsHarshad R Kulkarni, Vikas Prasad, Daniel Kaemmerer, Merten Hommann, Richard P Baum
JournalRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (Recent Results Cancer Res) Vol. 194 Pg. 373-8 ( 2013) ISSN: 0080-0015 [Print] Germany
PMID22918769 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Gallium Radioisotopes
  • Radiopharmaceuticals
  • Octreotide
  • Edotreotide
Topics
  • Aged
  • Female
  • Gallium Radioisotopes (pharmacokinetics)
  • Humans
  • Male
  • Middle Aged
  • Multimodal Imaging (methods)
  • Octreotide (analogs & derivatives, pharmacokinetics)
  • Positron-Emission Tomography
  • Radiopharmaceuticals (pharmacokinetics)
  • Spleen (metabolism)
  • Splenosis (diagnostic imaging)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: